BELLO, LUCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.461
EU - Europa 1.153
AS - Asia 765
AF - Africa 7
OC - Oceania 5
SA - Sud America 4
Continente sconosciuto - Info sul continente non disponibili 2
Totale 8.397
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.451
IT - Italia 565
CN - Cina 360
SG - Singapore 308
SE - Svezia 142
FI - Finlandia 115
GB - Regno Unito 100
FR - Francia 82
DE - Germania 55
HK - Hong Kong 21
UA - Ucraina 20
VN - Vietnam 20
IN - India 18
IE - Irlanda 16
TR - Turchia 14
NL - Olanda 13
ES - Italia 11
CA - Canada 8
IR - Iran 6
JP - Giappone 6
PL - Polonia 6
CH - Svizzera 4
MA - Marocco 4
AU - Australia 3
BE - Belgio 3
EG - Egitto 3
PK - Pakistan 3
SA - Arabia Saudita 3
AT - Austria 2
CO - Colombia 2
CZ - Repubblica Ceca 2
EU - Europa 2
HR - Croazia 2
HU - Ungheria 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
RO - Romania 2
RU - Federazione Russa 2
SI - Slovenia 2
TW - Taiwan 2
AR - Argentina 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
DK - Danimarca 1
GR - Grecia 1
GT - Guatemala 1
ID - Indonesia 1
IL - Israele 1
KR - Corea 1
LU - Lussemburgo 1
MX - Messico 1
PE - Perù 1
RS - Serbia 1
Totale 8.397
Salva come PNG Salva come JPEG
Città #
Fairfield 1.100
Woodbridge 654
Houston 520
Ashburn 474
Ann Arbor 470
Chandler 461
Seattle 393
Cambridge 362
Wilmington 327
Singapore 238
Boardman 183
San Diego 148
Santa Clara 132
Padova 125
Princeton 120
Medford 110
Beijing 102
Roxbury 92
Des Moines 86
Jacksonville 73
Helsinki 54
New York 46
Milan 40
Nanjing 37
Rome 25
London 23
Los Angeles 21
Dong Ket 20
Hong Kong 18
Nanchang 17
Dublin 16
Shenyang 16
Cagliari 15
Ovada 14
Hebei 12
Jinan 12
Norwalk 12
Ogden 12
Guangzhou 10
Phoenix 10
Changsha 9
Bari 8
Prescot 8
Venice 8
Hounslow 7
Lappeenranta 7
Bologna 6
Hefei 6
Jiaxing 6
Kilburn 6
Naples 6
Ningbo 6
Shanghai 6
Tianjin 6
Borås 5
Calvizzano 5
Dallas 5
Falls Church 5
Hangzhou 5
Palermo 5
Redwood City 5
Borgosatollo 4
Cadillac 4
Casablanca 4
Castellammare di Stabia 4
Castiglione Cosentino 4
Chicago 4
Dearborn 4
Florence 4
Fuscaldo 4
Istanbul 4
Kunming 4
Las Vegas 4
Ottawa 4
Pune 4
Rovigo 4
Trieste 4
Turin 4
Verona 4
Washington 4
Zhengzhou 4
Azzano San Paolo 3
Cairo 3
Castignano 3
Detroit 3
Ferrara 3
Fisciano 3
Genoa 3
Hemel Hempstead 3
Kharkiv 3
Lamezia Terme 3
Legnago 3
Mountain View 3
New Delhi 3
Palazzolo sull'Oglio 3
Quintanar de la Orden 3
Redmond 3
Riyadh 3
Rockville 3
Santa Maria La Carita 3
Totale 6.867
Salva come PNG Salva come JPEG
Nome #
Molecular bases of phenotypic and clinical variability in Duchenne and Becker muscular dystrophy 235
Non-neural phenotype of spinal and bulbar muscular atrophy: Results from a large cohort of Italian patients 197
SPP1 genotype and glucocorticoid treatment modify osteopontin expression in Duchenne muscular dystrophy cells 170
Parkinson-like features in ALS with predominant upper motor neuron involvement 152
Functional changes in Becker muscular dystrophy: Implications for clinical trials in dystrophinopathies 139
Cardiomyopathy in patients with POMT1-related congenital and limb-girdle muscular dystrophy. 135
TGFB2R but not SPP1 genotype modulates osteopontin expression in Duchenne muscular dystrophy muscle. 134
SPP1 genotype is a determinant of disease severity in Duchenne muscular dystrophy 127
Genetic modifiers of Duchenne muscular dystrophy and dilated cardiomyopathy 120
Muscle MRI in patients with dysferlinopathy: Pattern recognition and implications for clinical trials 119
Muscle MRI and functional outcome measures in Becker muscular dystrophy 116
Cognitive profile and MRI findings in limb-girdle muscular dystrophy 2I 116
Clinical and molecular characterization of limb girdle muscular dystrophy due to LAMA2 mutations. 114
Targeted gene panel screening is an effective tool to identify undiagnosed late onset Pompe disease 114
24 month longitudinal data in ambulant boys with duchenne muscular dystrophy. 112
Reliability of the North Star Ambulatory Assessment in a multicentric setting 109
P. 5.7 Limb-girdle muscular dystrophy type 2E: Clinical, genetic and histopathological features of 27 European patients 107
Safety and efficacy of edaravone compared to historical controls in patients with amyotrophic lateral sclerosis from North-Eastern Italy 106
Genetic modifiers of respiratory function in Duchenne muscular dystrophy 106
Assessment of patients with idiopathic inflammatory myopathies and isolated creatin-kinase elevation 102
Diagnostic and Prognostic Biomarkers in Amyotrophic Lateral Sclerosis: Neurofilament Light Chain Levels in Definite Subtypes of Disease 101
“I have got something positive out of this situation”: psychological benefits of caregiving in relatives of young people with muscular dystrophy 99
DMD genotypes and loss of ambulation in the CINRG Duchenne Natural History Study 99
Reliability of the Performance of Upper Limb assessment in Duchenne muscular dystrophy. 98
TNF-α-Induced microRNAs Control Dystrophin Expression in Becker Muscular Dystrophy 98
Teaching an old molecule new tricks: Drug repositioning for duchenne muscular dystrophy 98
Redefining phenotypes associated with mitochondrial DNA single deletion 96
Dystrophinopathies 95
Validation of the Italian version of the SBMA Functional Rating Scale as outcome measure 95
Molecular bases of phenotypic and clinical variability in Duchenne and Becker muscular dystrophy 94
Clinical and genetic spectrum in limb-girdle muscular dystrophy type 2E 93
Burden, professional support, and social network in families of children and young adults with muscular dystrophies 93
Pilot trial of clenbuterol in spinal and bulbar muscular atrophy. 92
The Role of Motor System in Mental Rotation: New Insights from Myotonic Dystrophy Type 1 92
Functional changes in Duchenne muscular dystrophy A 12-month longitudinal cohort study 91
The clinical spectrum of CASQ1-related myopathy 91
Benefits of glucocorticoids in non-ambulant boys/men with Duchenne muscular dystrophy: A multicentric longitudinal study using the Performance of Upper Limb test 90
Becker muscular dystrophy due to an intronic splicing mutation inducing a dual dystrophin transcript 89
Revisiting mitochondrial ocular myopathies: a study from the Italian Network 89
OPN-a induces muscle inflammation by increasing recruitment and activation of pro-inflammatory macrophages 88
No effect of AR polyG polymorphism on spinal and bulbar muscular atrophy phenotype 87
Association Study of Exon Variants in the NF-κB and TGFβ Pathways Identifies CD40 as a Modifier of Duchenne Muscular Dystrophy 87
Interpreting genetic variants in titin in patients with muscle disorders 85
6 minute walk test in Duchenne MD patients with different mutations: 12 month changes. 84
Timed rise from floor as a predictor of disease progression in Duchenne muscular dystrophy: An observational study 81
Importance of SPP1 genotype as a covariate in clinical trials in Duchenne muscular dystrophy. 80
Genetic modifiers of muscle: Studies of college students and Duchenne muscular dystrophy 80
Upper limb function in Duchenne muscular dystrophy: 24 month longitudinal data 80
Muscle MR Imaging in Tubular Aggregate Myopathy. 77
Evidence for ACTN3 as a genetic modifier of Duchenne muscular dystrophy 76
Lipomatosis incidence and characteristics in an Italian cohort of mitochondrial patients 74
Evaluation of peripherin in biofluids of patients with motor neuron diseases 74
Prednisone/prednisolone and deflazacort regimens in the CINRG Duchenne Natural History Study 72
Evaluation of mexiletine effect on conduction delay and bradyarrhythmic complications in patients with myotonic dystrophy type 1 over long-term follow-up 70
Non-Invasive Ventilation for Acute Respiratory Failure in Duchenne Muscular Dystrophy Patients 70
Teenage exercise is associated with earlier symptom onset in dysferlinopathy: a retrospective cohort study 69
Psychological and practical difficulties among parents and healthy siblings of children with Duchenne vs. Becker muscular dystrophy: an Italian comparative study 68
Cognitive profile in LGMD-2I 66
Discovery of serum protein biomarkers in the mdx mouse model and cross-species comparison to Duchenne muscular dystrophy patients 65
VBP15, a Novel Anti-Inflammatory, is Effective at Reducing the Severity of Murine Experimental Autoimmune Encephalomyelitis. 61
MYH7-related myopathies: Clinical, histopathological and imaging findings in a cohort of Italian patients 61
European muscle MRI study in limb girdle muscular dystrophy type R1/2A (LGMDR1/LGMD2A) 61
Italian version of the Rasch-Built Overall Amyotrophic Lateral Sclerosis Disability Scale (ROADS): validation and longitudinal performance 60
Osteopontin is linked with AKT, FoxO1, and myostatin in skeletal muscle cells 60
DGUOK recessive mutations in patients with CPEO, mitochondrial myopathy, parkinsonism and mtDNA deletions 59
The "Usual Suspects": Genes for Inflammation, Fibrosis, Regeneration, and Muscle Strength Modify Duchenne Muscular Dystrophy 59
Whole-Body Muscle Magnetic Resonance Imaging in Glycogen-Storage Disease Type III 56
Myotonic dystrophy type 1. CTG triplet expansion re-tested after 10 years: molecular and clinical considerations 55
North Star Ambulatory Assessment changes in ambulant Duchenne boys amenable to skip exons 44, 45, 51, and 53: A 3 year follow up 55
Ablation of collagen VI leads to the release of platelets with altered function 55
Genome-Wide Association Studies in Muscle Physiology and Disease 53
Whole genome sequencing reveals a 7 base-pair deletion in DMD exon 42 in a dog with muscular dystrophy 52
TCTEX1D1 is a genetic modifier of disease progression in Duchenne muscular dystrophy 52
Assessment of disease progression in dysferlinopathy: A 1-year cohort study 51
A Mutation in the CASQ1 Gene Causes a Vacuolar Myopathy with Accumulation of Sarcoplasmic Reticulum Protein Aggregates. 50
PROCEEDINGS OF THE XXI CONGRESS OF THE ITALIAN ASSOCIATION OF MYOLOGY: Digital EditionDecember 01-04, 2021 Neurofilament light chain and Profilin-1 in adult SMA patients under nusinersen treatment: 26-months follow-up 50
Integrated care of muscular dystrophies in Italy. Part 2. Psychological treatments, social and welfare support, and financial costs 49
Genetic modifiers of ambulation in the CINRG duchenne natural history study. 48
Genetic diagnosis as a tool for personalized treatment of Duchenne muscular dystrophy 48
Nusinersen safety and effects on motor function in adult spinal muscular atrophy type 2 and 3 48
Caregiver psychological profile and perceived quality of life in children affected by Duchenne Muscular Dystrophy 47
Mitochondrial disorders of the nuclear genome 47
Influence of β2 adrenergic receptor genotype on risk of nocturnal ventilation in patients with Duchenne muscular dystrophy 46
Large scale networks for human hand-object interaction: Functionally distinct roles for two premotor regions identified intraoperatively 46
A case of ‘never-experienced before’ headache in a young man. 45
Cognitive and neuroradiological profile in LGMD-2I 44
Movement Disorders in Children with a Mitochondrial Disease: A Cross-Sectional Survey from the Nationwide Italian Collaborative Network of Mitochondrial Diseases 44
Long-term natural history data in Duchenne muscular dystrophy ambulant patients with mutations amenable to skip exons 44, 45, 51 and 53 43
New genotype-phenotype correlations in a large European cohort of patients with sarcoglycanopathy 43
Assessing Dysferlinopathy Patients Over Three Years With a New Motor Scale 43
Quality of life assessment in adult spinal muscular atrophy patients treated with nusinersen 43
226thENMC International Workshop:. Towards validated and qualified biomarkers for therapy development for Duchenne muscular dystrophy 20-22 January 2017, Heemskerk, The Netherlands 42
Integrated care of muscular dystrophies in Italy. Part 1. Pharmacological treatment and rehabilitative interventions 40
Cognitive profile in LGMD-2I 37
A case of “never-experienced-before” headache in a young man. 37
Collagen VI deficiency causes behavioral abnormalities and cortical dopaminergic dysfunction 36
Extrapiramidal abnormalities in progressive external opthalmoplegia 35
Cardiorespiratory management of Duchenne muscular dystrophy: emerging therapies, neuromuscular genetics, and new clinical challenges 35
North Star Ambulatory Assessement, 6-minute walking test and timed items in ambulatory boys with Duchenne muscular dystrophy 34
Genetic modifiers of upper limb function in Duchenne muscular dystrophy 33
Totale 7.919
Salva come PNG Salva come JPEG
Categoria #
all - tutte 36.602
article - articoli 33.106
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 473
Totale 70.181
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.040 0 0 0 0 127 102 157 141 221 129 92 71
2020/20211.227 45 77 46 199 71 58 42 132 144 165 165 83
2021/20221.758 180 174 225 112 64 121 115 158 54 57 150 348
2022/20231.026 222 69 28 116 177 144 7 73 105 25 46 14
2023/2024836 16 70 83 65 60 93 83 57 52 60 97 100
2024/2025916 43 168 171 143 391 0 0 0 0 0 0 0
Totale 8.636